- Conditions
- Sepsis, Bacteremia, Fungemia
- Interventions
- MBI 226
- Drug
- Lead sponsor
- BioWest Therapeutics Inc
- Industry
- Eligibility
- 16 Years and older
- Enrollment
- 1,400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2003
- U.S. locations
- 1
- States / cities
- Lake Bluff, Illinois
Source: ClinicalTrials.gov public record
Updated Sep 13, 2005 · Synced May 21, 2026, 8:59 PM EDT